Guggenheim Capital’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $682K | Sell |
|
|||||
|
2025
Q2 | $576K | Buy |
|
|||||
|
2025
Q1 | $695K | Buy |
|
|||||
|
2024
Q4 | $770K | Sell |
|
|||||
|
2024
Q3 | $1.01M | Sell |
|
|||||
|
2024
Q2 | $953K | Sell |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $1.35M | Sell |
|
|||||
|
2023
Q3 | $1.22M | Sell |
|
|||||
|
2023
Q2 | $1.3M | Sell |
|
|||||
|
2023
Q1 | $1.18M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $346K | Sell |
|
|||||
|
2022
Q1 | $377K | Buy |
|
|||||
|
2021
Q4 | $425K | Sell |
|
|||||
|
2021
Q3 | $1.6M | Sell |
|
|||||
|
2021
Q2 | $1.75M | Sell |
|
|||||
|
2021
Q1 | $1.84M | Buy |
|
|||||
|
2020
Q4 | $3.25M | Buy |
|
|||||
|
2020
Q3 | $305K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $718K | Sell |
|
|||||
|
2018
Q4 | $522K | Sell |
|
|||||
|
2018
Q3 | $3.36M | Buy |
|
|||||
|
2018
Q2 | $4.07M | Buy |
|
|||||
|
2018
Q1 | $3.42M | Buy |
|
|||||
|
2017
Q4 | $3.02M | Sell |
|
|||||
|
2017
Q3 | $4.07M | Buy |
|
|||||
|
2017
Q2 | $2.56M | Sell |
|
|||||
|
2017
Q1 | $2.04M | Sell |
|
|||||
|
2016
Q4 | $1.52M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $2.53M | Buy |
|
|||||
|
2015
Q4 | $2.82M | Buy |
|
|||||
|
2015
Q3 | $2.13M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $84K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $56K | Sell |
|
|||||
|
2014
Q1 | $49K | Buy |
|
|||||
|
2013
Q4 | $47K | Buy |
|
|||||
|
2013
Q3 | $41K | Buy |
|
|||||
|
2013
Q2 | $32K | Buy |
|